Results 41 to 50 of about 2,734,684 (304)

Real‐World Pediatric Blinatumomab Administration: Access to Outpatient Care Delivery and Impact of a Hospital‐Dispensed Model

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Blinatumomab has been shown to be highly effective for patients with pediatric B‐ALL and has recently become standard of care therapy. Due to its past use in the clinical trial setting, there is limited information available about real‐world administration.
Katelyn Oranges   +12 more
wiley   +1 more source

Systematic notes on Sciapodinae from Baltic amber and on Dolichopodidae from Tanzanian copal (Diptera) [PDF]

open access: yesКавказский энтомологический бюллетень, 2008
Sciapodinae from Baltic amber are reviewed. All species with strongly sinuate vein M are united in one extinct genus Wheelerenomyia Meunier, 1907, including now 15 species.
I.Ya. Grichanov
doaj   +1 more source

New species and new combinations in Sonerila and Phyllagathis (Melastomataceae) from Thailand [PDF]

open access: yes, 1997
While revising the Melastomataceae for the Flora of Thailand, we discovered two new species of Sonerila, as well as the need for transferring two species of Tylanthera endemic to Thailand into Phyllagathis. Sonerila urceolata and S. loeiensis are endemic
Cellinese, Nicoletta, Renner, Susanne S.
core   +1 more source

New Names and New Combinations in Campanulaceae

open access: yesNovon, 1998
New names and new combinations are proposed for 15 species of Campanulaceae s.1. that have no legitimate name at that rank in the genus to which they should be assigned. These nomenclatural innovations include changes of genus and rank among the endemic Hawaiian Lobelioideae, the final installment in the incorporation of Pratia into Lobelia, and ...
openaire   +3 more sources

Personalized Selumetinib Dosing in Pediatric Neurofibromatosis Type 1: Insights From a Pilot Therapeutic Drug Monitoring Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate selumetinib exposure using therapeutic drug monitoring (TDM) in pediatric patients with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PN), assess interpatient pharmacokinetic variability, and explore the relationship between drug exposure, clinical response, and adverse effects.
Janka Kovács   +8 more
wiley   +1 more source

Adherence to Protocol Recommendations for Children With Wilms Tumour in Two Consecutive Studies in the United Kingdom and Ireland—Does Variation Matter?

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background and Aims Wilms tumour (WT) has excellent event‐free and overall survival (OS). However, small differences exist between countries participating in the same international study. This led us to examine variation in adherence to protocol recommendations as a potential contributing factor.
Suzanne Tugnait   +23 more
wiley   +1 more source

A synopsis of Tephrosia subgenus Barbistyla (Fabaceae) in southern Africa

open access: yesBothalia: African Biodiversity & Conservation, 1987
A synopsis of the southern African species of Tephrosia Pers. subgenus Barbistyla Brummitt is given. Twenty-one species are recognized. A new species, T. brummittii B. D. Schrire, is described and six new combinations are presented.
B. D. Schrire
doaj   +1 more source

New Synonymies and Combinations for New World Pselaphinae (Coleoptera: Staphylinidae) [PDF]

open access: yes, 1999
The following new synonymies and new combinations for Pselaphinae of North and Central America are documented: Anarmodius aequinoctialis (Motschulsky) (Trichonyx), New Comb.; Anthylarthron cornutum (Brendel) (= Anthylarthron curtipenne Casey, New Syn ...
Chandler, Donald S.
core   +1 more source

Gravitational Constraint Combinations Generate a Lie Algebra [PDF]

open access: yes, 1996
We find a first--order partial differential equation whose solutions are all ultralocal scalar combinations of gravitational constraints with Abelian Poisson brackets between themselves.
Arnowitt R   +17 more
core   +2 more sources

What’s new in melanoma? Combination! [PDF]

open access: yesJournal of Translational Medicine, 2015
Melanoma was again a focus of attention at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, in particular the use of combination treatment strategies involving immunotherapies and/or targeted agents. New data on targeted therapies confirmed previous findings, with combined BRAF inhibitor (vemurafenib) plus MEK inhibitor ...
Ascierto, Paolo A   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy